Syneos Health Inc. investors will have one final chance to state securities fraud claims over the Covid-19 pandemic’s effects after delivering a second impermissible “puzzle pleading,” a federal judge ruled.
Judge Arun Subramanian of the US District Court for the Southern District of New York declined March 28 to dismiss the proposed class action with finality because, he said, “it’s unclear whether or not there’s a viable case lurking underneath the surface.” Subramanian said he was giving specific guidance for the next version of the complaint “because apparently” his “prior instructions weren’t clear enough.”
- The investors alleged that the biopharmaceutical ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.